NEW YORK, Dec. 7, 2012 /PRNewswire/ -- PrecisionMD, the developer of innovative therapeutic and cosmetic skincare solutions, is excited to announce the Fall 2012 launch of DermaChromatic, the only product that uses a patent-pending copper-chlorophyllin anti-redness technology to visibly improve skin redness in as little as two weeks.
Over 13 million people suffer from redness, a chronic skin concern that can affect self-esteem and severely disrupt a patient's life. In a recent study by Dr. Lillian Ritu and Dr. Perry Robins of NY, DermaChromatic was shown to reduce the appearance of redness by 54 percent in just two weeks and by 68 percent in four weeks using a special camera that measures redness in the skin. The formula also helps reduce oiliness and reduces the appearance of pore size, conditions often associated with redness.
How does it work? DermaChromatic uses an exclusive copper-chlorophyllin complex that helps neutralize free radicals that cause red, irritated skin. Copper also helps even skin tone and reduce oiliness. The complex has been loaded into spherical lipid shells called liposomes that allow for the controlled release of the ingredients into skin. The result: more effective redness relieving results more quickly.
"DermaChromatic produces simply remarkable results in my practice. My patients with red and blotchy facial skin have noticed a dramatic reduction in the redness of their skin, plus they love the way the product feels as it's applied," says David B. Vasily, M.D., FAAD, co-inventor of DermaChromatic technology and board-certified dermatologist, Bethlehem, PA.
DermaChromatic is a non-irritating, oil-free, fragrance-free and paraben-free gel that works well on all skin types.
DermaChromatic is available at Dermatologist and other Aesthetic MD offices. For more information, visit www.precisionmdskin.com or call 1-888-423-5349. For before and after images see: http://www.precisionmdskin.com/dermachromatic/before-after/.
PrecisionMD is the sole distributor in the U.S. of DermaChromatic. To find an authorized PrecisionMD physician in your area, visit www.precisionmdskin.com/find-physician.
Headquartered in New York, NY, PrecisionMD is committed to developing, manufacturing and marketing innovative therapeutic and cosmetic skincare solutions that meet the dispensing needs of our physician partners and their patients, with brands including Vivatia, Dermaceutic, Relastin, DermaChromatic and CelfixDNA. PrecisionMD is supported by the shared state of the art FDA-approved research and production facilities of Precision Dermatology, Inc. in Cumberland, RI. PrecisionMD's President, Chief Executive Officer and Founder, Mr. Jeffrey Nugent, has over 25 years of dermatology and consumer skin and beauty care experience.